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                       Diabetes mellitus is a metabolic disorder and the disease management is an important 
measure for the pharmacotherapy. The medicinal plants play very vital role in preventing the advancement 
of the disease. The polyherbal extract was prepared from Eugenia Jambolana-seed and Cinnamomum 
zeylenicum-bark as hydro alcohol and aqueous extracts. The extracts were screened for invitro antidiabetic 
activity. Among all screened extracts the polyherbal extract APKJ-004 showed prominent invitro 
antidiabetic activity.  The present study was designed for assessment of toxicity and therapeutic efficacy of 
the selected polyherbal extract APKJ-004. The acute and sub acute toxicity were conducted in wistar rats. 
The results of toxicity assessment revealed that clinical, biochemical and Histopathological parameters 
studied were in normal range and comparable to controls. The study revealed that no toxic symptoms 
observed throughout the period of exposure. The invivo evaluation results showed that the extract APKJ-
004 reduced the elevated glucose levels (97.01± 6.23mg/dl) were comparable to the glibenclamide (89.3± 
7.42mg/dl). The insulin levels were considerably increased in polyherbal treated group from 06.75 ± 0.96 
µU/ml to 23.13±0.35µU/ml. The glucose tolerance test results revealed the absorption efficiency of APKJ 
004 was found to be 112.3± 6.68 mg/dl when compared with standard glibenclamide (93.4±4.67mg/dl) 
treated group at 120 min. Based on the above facts it is concluded that APKJ-004 polyherbal extract act as 
a potent antidiabetic agent with minimal or no side effects and useful in the pharmacotherapy of diabetes. 
Key words: Hypoglycemic Activity, polyherbal extract, Diabetes Mellitus, Streptozotocin Preclinical 
toxicity. 
INTRODUCTION 
Diabetes mellitus is a multifaceted metabolic disorder characterized by elevated blood glucose levels which 
results from defiency in insulin secretion, insulin action and or both1. The world wide increasing incidences 
on diabetes mellitus constitute a global public health problem reaching epidemic proportions2. 
Diabetes mellitus is considered to be a serious issue in many countries and traditional methods using 
medicinal plants to control diabetes is gaining momentum3. The allopathic medicine for control and 
management of diabetes without adverse effects is still a challenge for many researchers4. The synthetic 
hypoglycemic agent does produce serious side effects5 and whereas drug derived from medicinal plants are 
frequently consider being safe & cost effective. To avoid the side effects and effective treatment warrants 
the use of natural products6.  
Therefore the present study has been designed to evaluate the herbal preparations used to treat diabetes, as 
an alternative therapy but their reported hypoglycemic effects are multifarious. The Literature survey 
revealed that several NCE’s showed the antidiabetic activity but the study lacks the proper scientific 
validation and systematic evaluation7. Herbal preparations provide a useful source of new oral 
hypoglycemic agents for development as pharmaceutical entities or as simple dietary adjuvant to existing 
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therapies. The polyherbal extract have a proven efficacy compared to single plant extract8. 
Based on the invitro evaluations the identified formulation was subjected for preclinical toxicity studies. The 
present study has been designed to evaluate herbal preparations with suitable animal model to authenticate 
the invitro evaluations9,10. The extracts were subjected for acute, sub acute toxicity studies and evaluated as 
a hypoglycemic polyherbal preparation in animal model for determining its safety and efficacy. 
 
MATERIALS AND METHODS 
Materials: Streptozotocin (STZ) was purchased from Sigma, St Loius, MO, USA. Glibenclamide was gift 
from Bright labs, Hyderabad. Biochemical kits and all other chemical used were of analytical grade. 
Plant Extract: 
The plant materials Eugenia jambolana and Cinnamomum zeylenicum were collected from Acharya N.G 
Ranga University and taxonomic identification of the specimen was authenticated by Dr.P.Jayaraman, 
taxonomist at Plant Research Centre, Chennai and a voucher specimen wide Regd. No’s PARC/2010/893, 
PARC/2010/894 is preserved.  The polyherbal extract APKJ 004 was prepared by using hydro alcohol 
extract of EZ, hydro alcohol extract of CZ and aqueous extract of CZ. The extracts were extracted with ethyl 
alcohol (95%) and water at temperature (65-750C) using direct soxhlet method10. The solvents were 
evaporated under vacuum and reduced pressure at 400C using a rotary evaporator (HEI VAP Advantage 
Hl/HB/G3, Heidolf, Germany). Based on the invitro evaluations of single and combinations of the extracts 
the extract APKJ-004 (HAE-EZ; HAE-CZ and AQE-CZ (6:3:1)) has shown prominent hypoglycemic 
activity was further selected for studying efficacy and safety parameters for measuring its significance in the 
treatment of diabetes9.  
Experimental rats: 
Albino Wistar rats weighing between 160-200 g were procured from National Institute of Nutrition, 
Hyderabad, India. The animals were housed as per CPCSEA guidelines i.e., six animals per each 
polypropylene cage under standard conditions of temperature (22±3°C) and relative humidity (30-70%) with 
a 12:12 light: dark cycle under controlled environment (Regd.No. 1412/a/11/CPCSEA). The animals were 
fed with standard pellet diet (Mahaveer Enterprises feeds Ltd., Bangalore.) and water ad libitum. The 
animals were fasted for 18 hours before commencing the experiment. The study was approved by 
Institutional Animal Ethics Committee (IAEC) and designated by study code SOP/PS/IAEC/006. 
HPTLC analysis of the extract: 
HPTLC Finger print analysis of Eugenia jambolana and Cinnamomum zeylanicum and their combination as 
polyherbal extracts were performed on 10X10 cm HPTLC plates coated with 0. 5mm layer of silica gel 
60F254 (Merck, Darmstadt, Germany). Before using, the plates were washed with methanol and activated at 
110 degree centigrade for 5 min.  Samples were applied as 4mm wide bands and 6mm apart by using a 
Camag (Muttenz, Switzerland) Linomat IV sample applicator equipped with a 100ul syringe.  A constant 
application rate of 6ul/sec was used.  Mobile phase was Methanol:Chloroform:GAA (Glacial acetic acid) 
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(70:30:0.1), reducing agent vanillin H2SO4 and chromatograms were monitored at 600nm on HPTLC 
system12. 
Acute toxicity studies: 
The acute toxicity study was carried out by guidelines set by OECD 420 guidelines. Wistar rats (160-200g) 
maintained under standard laboratory condition was used. A total number of six animals were used per 
group which received a single dose (2000 and 5000mg/kg, b.wt (p.o.) of polyherbal drug.  Animals were 
kept overnight fasting prior to drug administration. After the administration of polyherbal drug, the food was 
withheld for 3-4 hours. Animals were observed individually at least once during the first 30 minutes after 
dosing, periodically during the first 24h (with special attention during the first 4 hours) and daily thereafter 
for a period of 14 days. Daily cage side observation included changes in skin and fur, eyes and mucous 
membrane (nasal) and also respiratory rate, circulatory, autonomic changes was observed13. 
Glucose Tolerance Test (GTT)   
Animals were fasted 18 hrs14 with free access to water and were separated in 5 groups of 6 rats each.  
Animals  of  all  groups  were  administered with  oral  D-glucose  solution 2  gm/kg   using oral gavages , 
Group  second ,third and  fourth  were  treated  orally  with  polyherbal extract  at  a  dose of 200, 400  
and 800 mg/kg b.wt., (p.o.) each for 30 min before the oral administration of glucose load. Control  animals  
were  treated  with  vehicle,  blood  sample  were  withdrawn  from  the  retro-orbital plexus region of  each  
animals under ether anesthesia   at   0  min,  30  min,  90  min  and  120  min  after  glucose  challenge  and  
the  fifth  group  received glibenclamide (2 mg/kg  as positive control). Blood glucose levels were estimated 
using GOD-POD kit (BioEra Life Sciences Pvt. Ltd., Pune). 
Streptozotocin induced Diabetes: 
Diabetes mellitus was induced to rats at a dose of 45 mg/kg/ body weight i.e., 5 ml of STZ (sigma chemical 
Co. USA) by intraperitoneal (i.p.) injection dissolved in 0.1M  citrate buffer, and equal volume of buffer was 
dosed in normal15. After forty eight hours of STZ administration, blood samples were withdrawn from retro 
orbital plexus and glucose levels were determined to confirm induction of diabetes.  The rats exhibiting 
>250 mg/dl were confirmed to be diabetic and they were selected for further studies. The grouping of were 
done accordingly Normal rats were injected with physiological saline as Group 1, Diabetic control were 
wistar rats receiving 0.5% CMC as vehicle as Group 2, diabetic rats receiving polyherbal extract (APKJ-
004) 200 mg/kg body weight as Group 3, Diabetic rats receiving polyherbal extract (APKJ-004) 400 mg/kg 
body weight as Group 4, Diabetic rats receiving polyherbal extract (APKJ-004) 800 mg/kg body weight as 
Group 5and finally Diabetic rats receiving 2mg/kg Glibenclamide drug as Group 6.  After blood collection, 
animals were culled using ether anesthesia and the vital organs were excised and subjected to further 
biochemical analysis. 
Biochemical and Hematological analysis 
Blood glucose was measured by using glucose-oxidase method16 Insulin was assayed by radio-immunoassay 
kit method (BioEra Life Sciences Pvt. Ltd., Pune). Biochemical and hematological analysis were carried out 
using Semi Auto Bio-Chemistry Analyzer (Optima S, LABINDIA) and hematological analyzer (PE- 6800 
VET, Procan Electronics) on termination day.  The effect of polyherbal extract APKJ-004 on vital organs 
such as kidney, liver, pancreas, heart etc., were determined on day 29. The body weight and food intake 
were monitored and recorded using animal weighing balance (Schimadzu, UXW-4200H) during 0,7, 14, 21 
and 28 days. 




On the termination day of the study the animals were sacrificed and dissected the required organs such as 
liver, pancreas, kidney, and heart and they were fixed in 10% formalin.  The sections of the tissues of 5-6µm 
were cut and stained with haemotoxylin and eosin stains. The tissue sections were subjected to rehydration 
by exposing them to decreasing concentration of alcohol i.e., 100-30%. Then the sections were stained with 
haemotoxylin. Later the sections were dehydrated by using increasing concentrations of alcohol and stained 
with eosin. Finally the sections were treated with DPX (Diphenylxylene) and mounted on to the slide for 
examination under microscope17. 
Statistical analysis 
All the data are reported as Mean±S.E. The results were statistically analyzed by one way analysis of 
variance (ANOVA) by Origin 7.6 software , followed by Duncans multiple range test (DMRT). P<0.05 was 
considered to be significant. 
 
RESULTS 
HPTLC finger printing analysis: 
Preliminary phytochemical analysis of APKJ -004 revealed presence of phenolic compounds, flavonoids, 
glycosides, alkaloids, carbohydrates, terpeniods and anthocyanins. HPTLC analysis indicated that the 
presence of seven distinct peaks.  The densitogram of HPTLC analysis on APKJ-004 were depicted in the 
Figure-1 
.  
FIGURE 1: Densitogram of polyherbal Extract- APKJ-004 determined by using CAMAG HPTLC 
analysis system 
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Acute toxicity study: 
The lethal dose 50 was determined in rats and none of the animals died at the dose of 2000mg/kg b.wt, and 
animals were survived at 5000 mg/kg b.wt. The LD50 of the polyherbal extract was found to be more than 
5000 mg/kg. During the observation period of 14 days, control and treated groups body weight, biochemical 
and hematological parameters were similar. There was no statistical difference when compared with 
controls. None of the animals died during the study and no abnormal behavior was observed in treated 
group. 
 
Sub acute toxicity Study: 
Sub acute toxicity studies on polyherbal extract APKJ-004 treated at 200,400 and 800 mg/kg b.wt., on rats 
for 28 days did not showed any abnormal changes in biochemical, hematological studies.  During the 
observation period the body weight increased throughout the exposure period when compared to that of 
control (initial 189.12±.18.3 and termination day 314.53±26.13, 171.42±10.30 on initial day to termination 
day 245.14±12.34 for male and female rats respectively). The results of the body weight of male and 
females rats were represented Figure-2. The absolute and relative organ weights were determined on 
termination day and were expressed as 100gm/wt. The weights measured on vital organs  at the termination 
day did not effect the organs and they are comparable to that of controls. The biochemical and hematological 
results were in the normal range.  The histopathological studies were subjected to pathological evalaution. 
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The blood glucose levels were increased from 80.5 ± 6.75to 268.01±31.14mg/dl in control group.  The 
treated group decreased the blood glucose level significantly p value >0.05.  In case of group 5 the blood 
glucose level was lowered significantly when compared with the control diabetic group at a dose of 
800mg/kg b.wt (97.01± 6.23mg/dl). The blood glucose levels were lowered in all the treated groups when 
compared to the diabetic control group in dose dependent manner. The glibenclamide treated group lowered 
the blood glucose level to the extent of 89.3 ± 7.42mg/dl.  
 
Plasma insulin  
The plasma insulin estimated in control group was of 6.75±0.96 µU/ml. The plasma insulin was 
significantly increased in group V 23.13±0.35 µU/ml when compared to that of the control group (p<0.05).  
The results of group V and group VI with glibenclamide are comparable and there was no difference in 
insulin release significantly (p=ns). Group 2 treated with STZ showed significant decrease in plasma insulin 
level and is highly significant when compared to control and normal (p<0.001). The results were tabulated in 
Table 1. 
TABLE 1: Effect of polyherbal herbal formulation (APKJ-004) on blood glucose, insulin levels in diabetic 
rats. 
Groups Description  Blood Glucose 
(mg/dl) 
 Insulin (µU/ml) 
I Normal  80.5 ± 6.75  14.59 ± 1.20 
II Diabetic control    268.01 ± 31.14  06.75 ± 0.96 
III Diabetic + APKJ-004 (200mg/kg)  143.33±5.45  11.31 ± 0.87 
IV Diabetic + APKJ-004 (400mg/kg)  128.4±6.67  18.34±0.45 
V Diabetic + APKJ-004 (800mg/kg)  97.01± 6.23  23.13±0.35 
VI Diabetic + Glibenclamide(2mg/kg)  89.3 ± 7.42  19.02 ± 0.82 
Data expressed as mean ± standard error (n=6 rats). The values of blood glucose were significant at p<0.05, the 
values of insulin were significant at p<0.004. 
GTT (Glucose Tolerance Test): 
Rats were subjected for the glucose tolerance test. The blood glucose levels were significantly increased in 
control group. There was significant decrease in the elevated blood glucose levels at 200,400 and 800 mg/kg 
(171±8.55, 148±7.47 and 112±6.70 mg/dl) when compare to that of control (190±9.51mg/dl). The 
decrease in blood glucose levels was dose dependent manner. The results were encouraging when the 
polyherbal extract were subjected to the glucose tolerance test (Figure 3). 


































FIGURE 3: Effect of polyherbal extract APKJ-004 on glucose tolerance test. Values are Mean±S.E, 
(n=6) and P values are significant at p<0.05. 
DISCUSSION: 
Diabetes mellitus is a chronic disease characterized by increased blood glucose levels and disturbances in 
the carbohydrate, fat and protein metabolism18. The preliminary phytochemical analysis revealed presence 
of phenolic compounds, tannins, flavonoids, glycosides, alkaloids and anthocyanins. Similar kinds of 
constituents were earlier reported19. Future study warrants for the identification, characterization and 
purification of the active components from polyherbal extract will give the clue for the lead molecules and 
chemical modification may yield good new chemical entity for the treatment of diabetes mellitus20.   
It is known that the efficacy and toxicity are important for assessing the therapeutic uses of the polyherbal 
extract.  Hence the acute and sub acute studies were carried out as per OECD guidelines and the results 
indicated that the polyherbal formulation used in the study do not have any toxicity related to behavior, 
clinical and biochemical parameters.  The increase in body weight and food intake is indicated the 
Padmanabha Rao Amarachinta International journal of ayurvedic & herbal medicine 2(2) April . 2012(218‐228) 
226 
 
healthiness of the control and treated animals. The LD50 values were >5000mg/kg b.wt. Hence it is classified 
as GHS (Global Harmonization System) category 5 as per the OECD guidelines. 
To determine the therapeutic efficacy of the polyherbal extract in the treatment of diabetes mellitus, the 
methods were chosen as described by Vogel. The study with respective to glucose tolerance test showed 
significant increase in the test carried out by oral route21.  The GTT reveals the influence of high blood 
glucose concentration and reveals the drug which affects the absorption of glucose. Taking this clue it was 
observed that glucose levels were significantly decreased indicating the therapeutic usefulness of polyherbal 
extract APKJ-004 in the treatment of diabetes mellitus.  The results were comparable with known 
antidiabetic drug glibenclamide. 
The streptozotocin induced diabetic animal showed significantly higher glucose levels when compared with 
normoglycemic agents22,23. The hyperglycemic activity in the control group was sustained but in polyherbal 
treated and glibenclamide decreased significantly.  This indicated the polyherbal extract evaluated has 
similar action to that of glibenclamide.  To prove the fact, the insulin release studies were done with control, 
polyherbal extract and glibenclamide.  The insulin release was higher when compare to the control 
streptozotocin induced group of animals.  The results indicated that the glibenclamide and polyherbal extract 
act in similar manner.  The initial approach has revealed that the formulation APLKJ-004 has shown 
reasonably good activity as an antidiabetic drug.  To determine the mechanism of action of polyherbal 
preparation are required to explore at the cellular level to have more direct evidence for the antidiabetic 
activity 24,25. 
CONCLUSIONS:  
Based on above studies it is concluded that the polyherbal APKJ 004 has many evidences to identify it as an 
oral hypoglycemic agent. Further a study at molecular level on the mechanism of this drug can give us a 
clear insight on its mode of action that makes it more effective than the commercially available standard 
drugs. The studies in these lines are in progress. 
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